Crystalline form of 1,1,1,3,3,3-Hexafluoropropan-2-yl (S)-1-(Pyridazin-3-ylcarbamoyl-)-6 Azaspiro[2.5]octane-6-carboxylate as monoacylglyerol lipase inhibitor

dc.assigneeLundbeck A/S
dc.contributor.authorVetter, Thomas
dc.contributor.authorWiener, John J. M.
dc.contributor.authorGrice, Cheryl A.
dc.contributor.authorBuzard, Daniel J.
dc.contributor.authorCisar, Justin S.
dc.contributor.authorWeber, Olivia D.
dc.contributor.authorAllan, Amy
dc.contributor.authorRaffaele, Nicholas
dc.contributor.authorMoody, Jeanne V.
dc.contributor.authorShaghafi, Michael B.
dc.date.accessioned2026-03-24T13:19:05Z
dc.date.issued2023-05-03
dc.identifier.patentWO2023213854A1
dc.identifier.urihttps://irf.fhnw.ch/handle/11654/56137
dc.publisherWorld Intellectual Property Organization
dc.subject.ddc540 - Chemie
dc.titleCrystalline form of 1,1,1,3,3,3-Hexafluoropropan-2-yl (S)-1-(Pyridazin-3-ylcarbamoyl-)-6 Azaspiro[2.5]octane-6-carboxylate as monoacylglyerol lipase inhibitor
dc.type12 - Patent
dspace.entity.typePublication
fhnw.InventedHereNo
fhnw.affiliation.hochschuleHochschule für Life Sciences FHNWde_CH
fhnw.affiliation.institutInstitut für Pharmatechnologie und Biotechnologiede_CH
relation.isAuthorOfPublication8334deb0-d1e5-410e-a54a-43d82d4dc525
relation.isAuthorOfPublication.latestForDiscovery8334deb0-d1e5-410e-a54a-43d82d4dc525
Dateien

Lizenzbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild
Name:
license.txt
Größe:
2.66 KB
Format:
Item-specific license agreed upon to submission
Beschreibung:
Herunterladen
Sammlung
Institut für Pharmatechnologie und Biotechnologie